In a significant announcement, President Trump is set to reveal a new drug pricing deal with AstraZeneca, following a similar agreement with Pfizer. This move aims to lower U.S. drug prices and pressure major drugmakers to bring manufacturing back to America. Will it lead to real savings for taxpayers?
In a bold move to reduce U.S. prescription drug prices, AstraZeneca and Pfizer have struck deals with the White House, promising significant discounts for patients. This comes amid rising pressure from President Trump on drugmakers to lower costs or face hefty tariffs. Will these changes truly benefit American patients?
In a surprising announcement, President Trump declared a 100% tariff on Chinese imports effective November 1, escalating tensions in the ongoing trade dispute. This bold move follows China's aggressive stance on trade and threatens to greatly impact the stock market.
President Trump threatens to cancel his meeting with Xi Jinping over China's new export rules on rare earths, escalating trade tensions and impacting financial markets.
As Trump's tariffs hit Switzerland with a staggering 39%, the Swiss economy faces serious consequences. With key industries at risk and potential job losses looming, how will Switzerland navigate the trade turmoil?
The Supreme Court kicks off a new term with a spotlight on Trump's assertion of executive power and critical cases affecting LGBTQ rights. Major rulings on tariffs and presidential authority are on the horizon.
As the Supreme Court opens a new term, it will tackle crucial issues surrounding presidential authority, including challenges to the Voting Rights Act and Trump's tariffs. The implications for the future of governance are monumental.
As the U.S. Supreme Court begins its new term, President Trump's recent judicial victories hang in the balance. Major rulings on executive power, tariffs, and civil rights could reshape America's legal landscape. Will the court uphold Trump's agenda or impose limits?
President Trump is contemplating significant tariff relief for U.S. automakers, potentially slashing costs for major companies like Ford and GM. This move could incentivize domestic production and create jobs, following his key policy goals.
U.S. consumer confidence declined sharply in September, driven by rising inflation and a weakening job market. With more Americans fearing a recession, the economic outlook appears grim.
